Saks Samuel R 4
4 · Protagonist Therapeutics, Inc · Filed Feb 26, 2021
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Common Stock
2021-02-26+12,000→ 14,000 total - Award
Stock Option (right to buy)
2021-02-26+90,000→ 90,000 totalExercise: $23.57Exp: 2031-02-25→ Common Stock (90,000 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024.
- [F2]Includes 2,000 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2020.
- [F3]The stock option vests in 48 equal monthly installments following the date of grant.